CLDX Insider Trading Activity and SEC Form 4 Filings
CLDX insider trading summary
Over the past 12 months, insiders at Celldex Therapeutics, Inc. (CLDX) reported 2 sales worth $1.3M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $1.3M.
Latest CLDX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 4, 2025 | Freddy A. Jimenez | SVP & General Counsel | Sell | $121K (4,166 @ $29.09) |
| Nov 13, 2025 | Richard M. Wright | Insider | Sell | $1.2M (49,298 @ $24.00) |
| Aug 13, 2025 | Freddy A. Jimenez | SVP & General Counsel | Sell | $8K (341 @ $23.95) |
| Aug 13, 2025 | Freddy A. Jimenez | SVP & General Counsel | Sell | $11K (430 @ $25.41) |
| Nov 11, 2024 | Anthony S Marucci | President & CEO | Buy | $308K (11,500 @ $26.82) |
| Jun 14, 2024 | Elizabeth Crowley | Sr. VP & Cpdo | Sell | $1.0M (30,000 @ $34.87) |
| Jun 14, 2024 | Samuel Bates Martin | SVP and CFO | Sell | $608K (17,172 @ $35.42) |
| Jun 7, 2024 | Elizabeth Crowley | Sr. VP & Cpdo | Sell | $526K (15,000 @ $35.06) |
| Jun 7, 2024 | Diane C. Young | SVP, Chief Medical Officer | Sell | $1.6M (45,000 @ $35.26) |
| Jun 3, 2024 | Freddy A. Jimenez | SVP & General Counsel | Sell | $269K (8,006 @ $33.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.